Ask Warren

Dongsung Pharmaceutical

002210 · KOSPI · ₩002210 · 동성제약

₩1,196▼ ₩27 (2.21%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy

Filings

  • Lawsuit filed or ruled소송등의판결ㆍ결정Sep 30, 2026Open on DART
  • Lawsuit filed or ruled소송등의판결ㆍ결정Sep 14, 2026Open on DART
  • Disclosure on Large Business Group Status [Quarterly Disclosure (For Individual Company)]대규모기업집단현황공시[분기별공시(개별회사용)]Aug 27, 2026Open on DART
  • Amended: Half-year report (Jun 2026)[기재정정]반기보고서 (2026.06)Aug 18, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
  • Matters Concerning Payment Amounts by Payment Method and Payment Period, and Dispute Mediation Bodies지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항Aug 14, 2026Open on DART
  • Other management matters기타경영사항(자율공시)Jul 29, 2026Open on DART
  • Other Market Notice (Announcement of KOSPI Listing Committee Deliberation Results and Decision to Maintain Listing)기타시장안내 (유가증권시장 상장공시위원회 심의결과 및 상장유지 결정 안내)Jul 29, 2026Open on DART
  • Other Market Notice (Addition of Grounds for Substantive Review of Listing Eligibility)기타시장안내 (상장적격성 실질심사 사유 추가 관련 안내)Jul 15, 2026Open on DART
  • Designation as Company for Unfaithful Disclosure불성실공시법인지정Jul 15, 2026Open on DART
  • Other Market Notice (Notice of Corporate Review Committee Decision to Continue Review)기타시장안내 (기업심사위원회 속행 결정 안내)Jun 23, 2026Open on DART
  • Notice of Planned Designation as Unfaithful Disclosure Company불성실공시법인지정예고Jun 23, 2026Open on DART
  • Occurrence of Embezzlement/Breach of Trust Suspicion횡령ㆍ배임혐의발생Jun 23, 2026Open on DART
  • [Corrected] Disclosure of Large Business Group Status [Annual Disclosure and Q1 Use (Individual Company)][기재정정]대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]Jun 4, 2026Open on DART
  • [Attachment Added] Disclosure of Corporate Governance Report[첨부추가]기업지배구조보고서공시Jun 1, 2026Open on DART
  • Disclosure of Large Business Group Status [Annual Disclosure and Q1 Use (Individual Companies)]대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]Jun 1, 2026Open on DART
  • Other Market Notice (Request for Deliberation on Whether Improvement Plan Has Been Implemented)기타시장안내 (개선계획 이행 여부 심의 요청)May 22, 2026Open on DART
  • Other Informational Disclosure (Informational Disclosure)기타안내사항(안내공시)May 20, 2026Open on DART
  • [Amended] Notice of Shareholder Register Closure Period or Record Date Setting[기재정정]주주명부폐쇄기간또는기준일설정May 15, 2026Open on DART
  • Amended: Shareholders' meeting called[기재정정]주주총회소집결의May 15, 2026Open on DART
  • Decision on Conclusion of Rehabilitation Procedures회생절차종결결정May 15, 2026Open on DART
  • Lawsuit filed or ruled소송등의제기ㆍ신청(일정금액이상의청구)May 15, 2026Open on DART
  • Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
  • Lawsuit filed or ruled소송등의판결ㆍ결정May 14, 2026Open on DART
  • Amended: Capital reduction decision[기재정정]주요사항보고서(감자결정)May 14, 2026Open on DART
  • Market Notice (End of Improvement Period and Future Procedures)기타시장안내 (개선기간 종료 및 향후 절차 안내)May 13, 2026Open on DART
  • Amended: Capital reduction decision[기재정정]주요사항보고서(감자결정)May 13, 2026Open on DART
  • Other management matters기타경영사항(자율공시)May 11, 2026Open on DART
  • Application for Termination of Rehabilitation Proceedings회생절차종결신청May 6, 2026Open on DART
  • Amended: Annual report (Dec 2025)[기재정정]사업보고서 (2025.12)May 6, 2026Open on DART
  • Amended: Annual report (Dec 2024)[기재정정]사업보고서 (2024.12)May 6, 2026Open on DART
  • Amended: Annual report (Dec 2023)[기재정정]사업보고서 (2023.12)May 6, 2026Open on DART
  • Amended: Audit report submitted[기재정정]감사보고서제출Apr 30, 2026Open on DART
  • Amended: Audit report submitted[기재정정]감사보고서제출Apr 30, 2026Open on DART
  • Amended: Capital reduction decision[기재정정]주요사항보고서(감자결정)Apr 29, 2026Open on DART
  • Amended: Capital reduction decision[기재정정]주요사항보고서(감자결정)Apr 24, 2026Open on DART
  • Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Apr 22, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Apr 22, 2026Open on DART
  • Amended: Capital reduction decision[기재정정]주요사항보고서(감자결정)Apr 17, 2026Open on DART
  • Amended: Capital reduction decision[기재정정]주요사항보고서(감자결정)Apr 16, 2026Open on DART
  • Change of Representative Director (Representative Executive Officer) (Informational Disclosure)대표이사(대표집행임원)변경(안내공시)Apr 15, 2026Open on DART
  • Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Apr 15, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 15, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 15, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 15, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Apr 15, 2026Open on DART
  • Amended: Other management matters[기재정정]기타경영사항(자율공시)Apr 14, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Apr 10, 2026Open on DART
  • Results of Rights Offering or Issuance of Equity-Linked Bonds, etc. (Voluntary Disclosure)유상증자또는주식관련사채등의발행결과(자율공시)Apr 9, 2026Open on DART
  • Amended: Capital reduction decision[기재정정]주요사항보고서(감자결정)Apr 9, 2026Open on DART

Titles in Korean until English translations are added.

Also known as: Dongsung Pharmaceutical / 동성제약 / 002210 / KRX:002210

Source: KRX statistical information